Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–18 of 18 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07188558
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, +16 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Scottsdale, Arizona, United States
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of Arkansas Little Rock, Arkansas, United States
NCT05826535
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- University of California-Irvine Medical Center Irvine, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California, Los Angeles (UCLA) Medical Center Los Angeles, California, United States
- Scripps Clinic San Diego, California, United States
NCT06839456
- Conditions
- Acquired Aplastic Anemia, Anemia, Anemia, Refractory, +35 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
Recruiting
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL
NCT06104592
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Recruiting
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
NCT06026319
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Grade 3b Follicular Lymphoma, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT06484920
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
NCT06550141
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311
- Conditions
- B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
- Locations
-
- University of California, Davis Sacramento, California, United States
- Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States
NCT06119685
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
- Emory University Hospital Atlanta, Georgia, United States
- University of Minnesota Minneapolis, Minnesota, United States
Recruiting
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma
NCT06158386
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT05967416
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- City of Hope Duarte, California, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- MD Anderson Cancer Center Houston, Texas, United States
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
Not Yet Recruiting
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07159906
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Not Yet Recruiting
First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma
NCT06097455
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- CHU Santiago de Compostela Santiago de Compostela, A Coruña, Spain
- Hospital Clínic Barcelona Barcelona, Spain
- H. Ramon y Cajal Madrid, Spain
- H.U. Virgen de la Arrixaca Murcia, Spain
Not Yet Recruiting
Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)
NCT05746858
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Istituto Nazionale Tumori Fondazione "G. Pascale" IRCCS Naples, Italy
- Fonadazione Policlinico Universitario A. Gemelli Roma, Italy
- Istituti Fisioterapici Ospitalieri -Istituto Regina Elena Roma, Italy
NCT02181478
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +35 more
- Locations
-
- Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
NCT05621096
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +17 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States